NanoViricides Has Filed its Quarterly Report
Accesswire
*NV-387 Advancing to Phase II Clinical Trial for the Treatment of RSV Infection*
*SHELTON, CT / ACCESSWIRE / May 15,..
*NV-387 Advancing to Phase II Clinical Trial for the Treatment of RSV Infection*
*SHELTON, CT / ACCESSWIRE / May 15,..
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules
· Pyzchiva^® approved as one of first..
This Day in History, March 14